Bank Of New York Mellon Corp Aptevo Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.74 - $2.54 $35,765 - $52,209	20,555 New	20,555 $41.8 Million
Q4 2022 Feb 14, 2023	BUY	$2.0 - $138.16 $41,110 - $2.84 Million	20,555 New	20,555 $47,000
Q2 2022 Aug 15, 2022	SELL	$3.26 - $6.3 $17,131 - $33,106	-5,255 Reduced 20.25%	20,697 $74,000
Q1 2022 May 11, 2022	BUY	$4.48 - $8.42 $71,626 - $134,618	15,988 Added 160.46%	25,952 $152,000
Q1 2021 May 13, 2021	BUY	$27.86 - $40.59 $277,597 - $404,438	9,964 New	9,964 $304,000

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $24.5M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.